Bioherent is a provider of diagnostic test for drug allergies.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City:
State:
Zip:
Country:
Bioherent develops in vitro diagnostic systems for the detection of allergies to beta-lactam antibiotics. Bioherent is based on integrated photonic sensors, and the company provides medical diagnostic tests for the detection of drug allergies. It develops sensitive, low-cost, in-vitro medical diagnostic technology. They develop in vitro diagnostic systems for the detection of allergies to beta-lactam antibiotics.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | Seed Round | 1 | - |
Bullnet Capital Bullnet Capital |
2/2022 | Venture Round | 2 | $1.5M |
Bullnet Capital Centre for the Development of Industrial Technology (CDTI) Bullnet Capital Centre for the Development of Industrial Technology (CDTI) |
7/2021 | Seed Round | 1 | - |
Bullnet Capital Bullnet Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|